Kosiakova N P, Pavliuchenkova R P
Vopr Virusol. 1986 Mar-Apr;31(2):205-10.
Solid-phase radioimmunoassay (SPRIA) was used for examinations of human malignant tumors for the presence of retrovirus D-induced antigen and of blood sera from cancer patients for the presence of antibody to this antigen. Various tumor specimens differently reacted to anti-HEp-2 serum, the background values of binding of this serum with normal tissues (liver, lung, spleen) and leukemic cells from leukemia patients being low. The majority of the sera from cancer patients were found to contain antibody to HEp-2 antigen. No correlation was established between high levels of the antigen in tumors and high antibody titres in the blood sera of the same patients.
采用固相放射免疫测定法(SPRIA)检测人类恶性肿瘤中是否存在逆转录病毒D诱导抗原,以及癌症患者血清中是否存在该抗原的抗体。各种肿瘤标本对抗HEp-2血清的反应不同,该血清与正常组织(肝脏、肺、脾脏)以及白血病患者白血病细胞的结合背景值较低。发现大多数癌症患者血清中含有抗HEp-2抗原的抗体。在同一患者的肿瘤中该抗原的高水平与血清中的高抗体滴度之间未建立相关性。